Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Augmentin
Generic name / active ingredient
amoxicillin and clavulanate potassium
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • 250 mg/125 mg, 500 mg/125 mg and 875 mg/125 mg each state amounts for both amoxicillin and clavulanate. A total milligram number or either number alone does not identify the complete product. First check both ingredients, dosage form and target market.
  • This public label explicitly states that two 250 mg/125 mg tablets should not be substituted for one 500 mg/125 mg tablet because the clavulanate component differs. This is a product-identity and label-reading point, not a formula for self-adjusting the number of tablets.
  • Oral suspension is labelled as two ingredients per 5 mL. Different concentrations, measuring devices, reconstitution and storage requirements must follow the current label and prescription for the actual bottle. Tablet numbers cannot be directly converted into a child’s or adult’s millilitre amount.
  • A score mark, chewable tablet or suspension appearance can be an identification clue, not permission to split, crush, substitute or combine products. With allergy history, gastrointestinal symptoms, multiple medicines or a need to adjust treatment, take the actual pack and complete medicine list to a clinician or pharmacist.

Reviewed presentation examples — compare every field

  • 250 mg / 125 mg per tablet; 30-tablet bottle (FDA U.S. 2026 label text)NDC 81964-018-30
  • 500 mg / 125 mg per tablet; 20-tablet bottle (FDA U.S. 2026 label text)NDC 81964-006-14
  • 875 mg / 125 mg per tablet; 20-tablet bottle (FDA U.S. 2026 label text)NDC 81964-021-14

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image